Platinum refractory cancers are cancers that do no respond to treatment with cancer therapies containing platinum such as carboplatin and cisplatin
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated